Founded in November 2023 in Cairo, Biosyn Pharmaceuticals is an emerging company with a global mindset — committed to delivering premium-quality, accessible medications where they're needed most.
Biosyn emerged from the conviction that quality medication should never be a privilege. We are an Egyptian pharmaceutical company blending scientific rigor, ethical sourcing, and human-centered design to deliver therapies that matter.
We focus where we can make the deepest impact: Pediatrics, Otolaryngology, and Pulmonology — three areas where formulation precision, safety, and accessibility define the difference between care and cure.
We honor every individual — patient, partner, professional. Dignity is the starting point of every interaction.
To quality. To accessibility. To outcomes that matter. We measure ourselves by what we deliver.
Pharmaceutical excellence demands rigor. We follow process, science, and protocol — without exception.
Healthcare is collective work. We collaborate across science, operations, and care.
We celebrate progress, not posture. Real outcomes — for patients, partners, and the field — are how we define winning.
Rather than spread thin, we go deep — focusing on the areas where formulation precision and patient safety matter most.
Pediatric care demands precision: gentle dosing, palatable formulations, and absolute safety. We design with smaller patients in mind — medications built for them, not adapted from adults.
Ear, nose, and throat conditions touch millions daily. Our ENT portfolio focuses on nasal care: isotonic and hypertonic sprays, soothing gels, and innovative formulations that bring measurable relief.
Respiratory health is central to quality of life. Our pulmonology focus addresses chest and respiratory conditions with formulations engineered for efficacy, tolerability, and patient adherence.
Innovation at Biosyn means asking the right questions: What's missing in the market? What can be better? How do we make a complex formulation safer, more stable, more accessible?
Excipient compatibility, stability profiling, and patient-centric design.
Continuous mapping of unmet needs across Egyptian and regional markets.
Bench-to-batch transitions designed for consistency and reliability.
Every Biosyn product moves through a layered framework of verification — from raw material sourcing to final batch release.
Manufactured under strict GMP-compliant facilities and processes.
All products registered and notified with the Egyptian Drug Authority.
Raw materials, in-process samples, and final products triple-verified.
Active post-market safety monitoring and adverse event tracking.